Holen Sie sich die Stockscreener-App
1.86
9.27%
-0.19
Vorhandelsmarkt:
1.77
-0.09
-4.84%
Schlusskurs vom Vortag:
$2.05
Offen:
$3.47
24-Stunden-Volumen:
161.62M
Relative Volume:
63.04
Marktkapitalisierung:
$10.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.66M
KGV:
-0.2281
EPS:
-8.156
Netto-Cashflow:
$-11.09M
1W Leistung:
-13.97%
1M Leistung:
-22.18%
6M Leistung:
-5.10%
1J Leistung:
-40.38%
1-Tages-Spanne:
$1.7201
$4.1899
1-Wochen-Bereich:
$1.7201
$4.1899
52-Wochen-Spanne:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Firmenname
Phio Pharmaceuticals Corp
Sektor
Branche
Telefon
(508) 767-3861
Adresse
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Vergleichen Sie PHIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
1.86 | 11.74M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-05 | Eingeleitet | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten
Phio Pharmaceuticals raises $13.4 million through warrant exercise By Investing.com - Investing.com Nigeria
Phio Pharmaceuticals Stock Falls 5% Amid Financing And Clinical Updates - Nasdaq
Phio Pharmaceuticals raises $13.4 million through warrant exercise - Investing.com
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds - Newsfile
Why Is Phio Pharmaceuticals Stock Soaring Today? - Benzinga
Why Is Phio Pharmaceuticals Stock Up 75% Today? - TipRanks
Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks
How Phio Pharmaceuticals Corp. stock benefits from tech adoptionChart Signals & AI Optimized Trading Strategy Guides - newser.com
Phio Pharmaceuticals Corp Announces Positive Results in Skin Cancer Trial - TradingView
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial - Newsfile
Is Phio Pharmaceuticals Corp. stock attractive for retirement portfolios2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Best data tools to analyze Phio Pharmaceuticals Corp. stockLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Phio Pharmaceuticals Corp. stock retracement – recovery analysisMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulations2025 Price Momentum & Risk Managed Trade Strategies - newser.com
How currency fluctuations impact Phio Pharmaceuticals Corp. stockTrade Exit Report & Comprehensive Market Scan Insights - newser.com
Can Phio Pharmaceuticals Corp. hit a new high this month2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Is Phio Pharmaceuticals Corp. stock in correction or buying zone2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. dataWeekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Can Phio Pharmaceuticals Corp. rally from current levelsQuarterly Investment Review & Safe Entry Trade Reports - newser.com
What to do if you’re stuck in Phio Pharmaceuticals Corp.Quarterly Profit Report & Real-Time Buy Signal Notifications - newser.com
Top chart patterns to watch in Phio Pharmaceuticals Corp.Rate Cut & Technical Pattern Recognition Alerts - newser.com
Phio Pharmaceuticals appoints David Deming as lead independent director By Investing.com - Investing.com Australia
What drives Phio Pharmaceuticals Corp 44R1 stock priceAnalyst Downgrades & Access Insider-Level Stock Analysis - earlytimes.in
Phio Pharmaceuticals Corp. (PHIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Phio Pharmaceuticals Appoints New Lead Independent Director - TipRanks
Phio Pharmaceuticals Corp. Announces Appointment of David H. Deming as Lead Independent Director - MarketScreener
[8-K] Phio Pharmaceuticals Corp. Reports Material Event | PHIO SEC FilingForm 8-K - Stock Titan
Phio Pharmaceuticals appoints David Deming as lead independent director - Investing.com
Phio Pharmaceuticals Announces Board Resignation - TradingView
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director - Newsfile
Phio (NASDAQ: PHIO) names David H. Deming lead independent director, with over 30 years - Stock Titan
Is Phio Pharmaceuticals Corp. stock supported by strong fundamentalsPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Will Phio Pharmaceuticals Corp. stock outperform tech sector in 2025GDP Growth & Pattern Based Trade Signal System - newser.com
Using economic indicators to assess Phio Pharmaceuticals Corp. potential2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com
Will Phio Pharmaceuticals Corp. stock rally after Fed decisionsShort Setup & Low Drawdown Momentum Ideas - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock included in top ETFsWeekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):